2Gunton JE,Stiel J,Clifton-Bligh P,et al.Prevelence of posotive antinertrophilic cytoplasmic antibody(ANCA) in patients receiving anti-thyroid medication[J].Eur J Endocr,2000,142(6):587-590.
3Wada N,Mukai M,Kohno M,et al.Prevalence of serum antimyeloperoxidase antineutrophil cytoplasmic antibodies (MPO-ANCA) in patients with Grave's disease treated with propylthiouracil and thiamazole[J].Endocr J,2002,49(3):329-334.
4Sera N,Ashizawa K,Ando T,et al.Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves'disease[J].Thyroid,2000,10(7):595-599.
5Sato H,Hattori M,Fujieda M,et al.High prevalence of Graves′ disease treated with propylthiouracil[J].J Clin Endocrinol Metab,2000,85(11):4270-4273.
5[2]Stone J H,Calabrese L H,Hoffman G S,et al.Vasculitis:aCollection of Pearls and Myths[J].Rheum Dis Clin NorthAm,2001,27(4):677-728.
6[3]Guillevin L,Lhote F.Treatment of Polyarteritis Nodosa andMicroscopicPolyangiitis[J].ArthritisRheum,1998,41:2100-2105.
7Dolman KM, Gans RO, Vervaat TJ, et al. Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy. Lancet, 1993, 342: 651-652.
8Wada N, Mukai M, Kohno M, et al. Prevalence of serum antimyeloperoxidase antineutrophil cytoplasmic antibodies ( MPOANCA) in patients with Graves′ disease treated with propylthiouracil and thiamazole. Endocr J,2002 ,49:329-334.
9Sera N, Ashizawa K, Ando T, et al. Treatment with propylthiouracil is associated with appearance of antineutrophil cytoplasmic antibodies in some patients with Graves′ disease. Thyroid,2000,10:595-599.
10Sato H, Hattori M, Fujieda M, et al. High prevalence of antineutrophil cytoplasmic antibody positivity in childhood onset Graves′ disease treated with propylthiouracil. J Clin Endocrinol Metab, 2000,85:4270-4273.
